Skip to main content

News

Press Release
06/09/2023
The non-profit organization Arrhythmia Alliance hosted an award ceremony at The Palace of Westminster, London, UK during World Heart Rhythm Week (05 June to 11 June 2023) to acknowledge leading clinicians as Healthcare Pioneers in their...
The non-profit organization Arrhythmia Alliance hosted an award ceremony at The Palace of Westminster, London, UK during World Heart Rhythm Week (05 June to 11 June 2023) to acknowledge leading clinicians as Healthcare Pioneers in their...
The non-profit organization...
06/09/2023
EP Lab Digest
Press Release
06/07/2023
AMSTERDAM, June 7, 2023 /- AliveCor, the global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking collaboration with Luscii, Europe's market leader in remote patient monitoring and virtual ward provider....
AMSTERDAM, June 7, 2023 /- AliveCor, the global leader in personal electrocardiogram (ECG) technology, has announced a groundbreaking collaboration with Luscii, Europe's market leader in remote patient monitoring and virtual ward provider....
AMSTERDAM, June 7, 2023 /-...
06/07/2023
EP Lab Digest
Press Release
06/06/2023
New York, NY (June 6, 2023) – Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the...
New York, NY (June 6, 2023) – Mount Sinai researchers have developed an innovative artificial intelligence (AI) model for electrocardiogram (ECG) analysis that allows for the interpretation of ECGs as language. This approach can enhance the...
New York, NY (June 6, 2023) –...
06/06/2023
EP Lab Digest
Press Release
06/06/2023
The non-profit organization Arrhythmia Alliance announces the launch of the first SVT Awareness Day June 07 during World Heart Rhythm Week (June 05 to June 11 2023).
The non-profit organization Arrhythmia Alliance announces the launch of the first SVT Awareness Day June 07 during World Heart Rhythm Week (June 05 to June 11 2023).
The non-profit organization...
06/06/2023
EP Lab Digest
Press Release
06/05/2023
Transformational, Versatile, Patient-worn, Continuous Vital Signs Monitor Features Wide Range of Physiological Measurements on a Compact, Scalable Platform
Transformational, Versatile, Patient-worn, Continuous Vital Signs Monitor Features Wide Range of Physiological Measurements on a Compact, Scalable Platform
Transformational, Versatile,...
06/05/2023
EP Lab Digest
Press Release
06/05/2023
BASKING RIDGE, N.J. & SHIRLEY, N.Y.-- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose...
BASKING RIDGE, N.J. & SHIRLEY, N.Y.-- Daiichi Sankyo, Inc. and American Regent, Inc., a Daiichi Sankyo Group company, today announced that the U.S. Food and Drug Administration (FDA) approved INJECTAFER® (ferric carboxymaltose...
BASKING RIDGE, N.J. &...
06/05/2023
Cath Lab Digest
Press Release
06/02/2023
At the outset of National CPR and AED Awareness Week, the NFL announced that it has expanded The Smart Heart Sports Coalition to 26 member organizations.
At the outset of National CPR and AED Awareness Week, the NFL announced that it has expanded The Smart Heart Sports Coalition to 26 member organizations.
At the outset of National CPR...
06/02/2023
EP Lab Digest
Press Release
05/30/2023
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes
INPEFA granted broad label across full range of left ventricular ejection fraction, including HFpEF and HFrEF, and for patients with or without diabetes
INPEFA granted broad label...
05/30/2023
EP Lab Digest
Press Release
05/25/2023
The Librexia program evaluating milvexian is unrivaled as the most comprehensive factor XIa inhibitor clinical development program to date and will provide extensive data from nearly 50,000 patients, with all three studies underway
The Librexia program evaluating milvexian is unrivaled as the most comprehensive factor XIa inhibitor clinical development program to date and will provide extensive data from nearly 50,000 patients, with all three studies underway
The Librexia program evaluating...
05/25/2023
EP Lab Digest
Press Release
05/25/2023
May 24, 2023 09:00 AM Eastern Daylight Time--CHELMSFORD, Mass.--ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the United States Food and Drug...
May 24, 2023 09:00 AM Eastern Daylight Time--CHELMSFORD, Mass.--ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the United States Food and Drug...
May 24, 2023 09:00 AM Eastern...
05/25/2023
EP Lab Digest